Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
Cardiovascular and Interventional Radiology|April 12, 2022
Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective StudyTao Ouyang, Yanyan Cao, Lei Chen, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 22, 2024
Efficacy Analysis of PTCD + TACE vs PTCD + Apatinib in the Treatment of HCC with Obstructive Jaundice: A Retrospective StudyHaohao Lu, Bin Liang, Xiangwen Xia, et al.
Current Radiopharmaceuticals|December 1, 2023
Analysis of the Efficacy and Safety of Palonosetron Hydrochloride in Preventing Nausea And Vomiting After TACE: A Retrospective AnalysisHaohao Lu, Chuansheng Zheng, Bin Liang, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 2, 2022
Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective StudyHaohao Lu, Chuansheng Zheng, Bin Liang, et al.
Oncotarget|November 8, 2017
Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled studyQi Yao, Hongsen Zhang, Bin Xiong, et al.
BMC Urology|January 14, 2022
Analysis of long-term effect of ureteral balloon dilatation combined with internal and external drainage tube in the treatment of benign ureteral strictureHaohao Lu, Chuansheng Zheng, Bin Liang, et al.
Interactive Cardiovascular and Thoracic Surgery|September 24, 2021
Successful treatment of atypical type A aortic dissection after heart transplantationShenglei Shu, Lan Cheng, Jing Wang, et al.
BMC Cancer|March 14, 2023
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinomaHaohao Lu, Chuansheng Zheng, Bin Xiong, et al.
BMC Gastroenterology|November 19, 2022
Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegalyHaohao Lu, Chuansheng Zheng, Bin Xiong, et al.
BMC Cancer|October 25, 2023
Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective studyHaohao Lu, Bin Liang, Xiangwen Xia, et al.
Pageof 33